What new and emerging osteoporosis therapies are in development?
- • Antiresorptive drugs
- • New SERMs: lasofoxifene, bazedoxifene, arzoxifene
- • Osteoanabolic drugs
- • Teriparatide: transdermal, intranasal
- • Abaloparatide: transdermal
- • Sclerostin inhibitors: antisclerostin antibody (romosozumab)
- • Calcilytic (stimulates endogenous PTH release): ronacaleret
- • Tryptophan hydroxylase 1 (Tph 1) inhibitor: inhibit gut-derived serotonin
